Ritu Ojha

Taipei, TNQ 11003, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies.

Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: June 26, 2026

Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics.

Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 16, 2026

Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent.

Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent.

Journal: Journal of medicinal chemistry

Published: December 15, 2021

Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].

Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].

Journal: European journal of medicinal chemistry

Published: June 12, 2020

Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.

Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.

Journal: European journal of medicinal chemistry

Published: November 11, 2019

Steering the antitumor drug discovery campaign towards structurally diverse indolines.

Steering the antitumor drug discovery campaign towards structurally diverse indolines.

Journal: Bioorganic chemistry

Published: August 01, 2019

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.

Journal: European journal of medicinal chemistry

Published: August 15, 2018

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.

Journal: European journal of medicinal chemistry

Published: December 10, 2017

Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.

Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.

Journal: European journal of medicinal chemistry

Published: October 04, 2016

Early investigational tubulin inhibitors as novel cancer therapeutics.

Early investigational tubulin inhibitors as novel cancer therapeutics.

Journal: Expert opinion on investigational drugs

Published: May 18, 2016

Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.

Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.

Journal: European journal of medicinal chemistry

Published: September 19, 2015

Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors.

Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: March 24, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026